(Reuters) – UBS executives have sold millions in shares since the Swiss bank announced its second quarter results, according to filings on the SIX stock exchange website. Since the start of September, UBS shares worth more than 14 million Swiss francs ($15.68 million) were sold in five transactions by executive members of the board of …
UBS executives sold over $15 million shares in September Read More »
By Harry Robertson LONDON (Reuters) – The pound hovered just above a three-month low on Friday, and was set for a 0.9% weekly fall, after hiring data added to signs of a slowdown in Britain’s jobs market. Sterling was last up just 0.06% at $1.2483, after falling to $1.2445 on Thursday, the lowest since June …
Sterling hovers at three-month low after weak hiring data Read More »
MADRID (Reuters) – Spain’s acting labour minister on Friday called on the government to block the acquisition by Saudi Arabia’s STC Group of a 9.9% stake in Telefonica, for the first time signalling opposition to the deal within the coalition. “My opinion is that we cannot allow this operation to continue,” Yolanda Diaz, who belongs …
Spanish minister calls for govt to block STC’s push for 9.9% Telefonica stake Read More »
(Reuters) – A union representing workers at General Motors, Ford Motor and Jeep-maker Stellantis has threatened strikes if a contract deal is not reached before the current ones expire on Sept. 14 at midnight. A strike would ground production to a halt, costing billions of dollars in losses for automakers as well as their suppliers. …
Factbox-Impact of possible strikes on Detroit Three automakers Read More »
By Ahmad Ghaddar LONDON (Reuters) – Ship-to-ship transfers of Russia’s Urals crude oil grade in August were about 85% lower than their peak in the first quarter of this year, according to analytics firm Vortexa, amid warmer weather and Moscow’s decision to cap exports. Ship-to-ship (STS) transfers of Russian Urals averaged 60,000 barrels per day …
Russian Urals STS shipments slump 85% from their Q1 peak: Vortexa Read More »
(Reuters) – Annual inflation in Russia was 5.15% in August, up from 4.30% in July, according to Russia’s statistics service. A Reuters poll had suggested that annual inflation would rise to 5.1% in August. In monthly terms, inflation in August was 0.28%. The poll had indicated it would be around 0.3%. (Reporting by Reuters; Editing …
Russian inflation rises to 5.15% yr/yr in August; monthly inflation is 0.28% Read More »
By Siddarth S and Shubham Batra (Reuters) -London stocks had their best day in a week on Friday after a survey signalled slower hiring activity in August, cementing bets that the Bank of England will pause its interest rate hikes with more signs of a cooling labour market. The exporter-heavy FTSE 100 index rose 0.5%, …
UK stocks rise as slower August hiring boosts rate pause optimism Read More »
By Nora Buli OSLO (Reuters) -Offshore wind developers stayed away from Britain’s latest renewable energy auction on Friday, arguing the price offered by the government did not reflect rising industry costs, something which is hampering wind projects globally. The result was bad news for Britain’s 2050 net zero emissions target, which calls for 50 gigawatts …
Offshore wind drops out of UK auction on costs, risking climate goals Read More »
By Sruthi Shankar (Reuters) – Early gains in European stocks faded on Friday, with the benchmark STOXX 600 heading for its eighth consecutive session of losses as investors grew nervous over the trajectory of U.S. interest rates and the outlook for the European economy. The pan-European STOXX 600 index fell 0.6%, putting it on course …
European stocks head towards longest losing run since 2016 Read More »
(Reuters) -Eli Lilly’s diabetes drug Mounjaro has gained the backing of Britain’s healthcare cost-effectiveness watchdog, which said it would be a good option for patients with poorly controlled type 2 diabetes. The National Institute for Health and Care Excellence (NICE) said in draft final guidance that it estimates some 180,000 people could benefit from the …
Lilly’s diabetes drug Mounjaro approved by UK watchdog Read More »
